These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ. J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138 [Abstract] [Full Text] [Related]
3. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K. J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858 [Abstract] [Full Text] [Related]
4. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. von Lutterotti N, Camargo MJ, Campbell WG, Mueller FB, Timmermans PB, Sealey JE, Laragh JH. J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376 [Abstract] [Full Text] [Related]
5. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model]. Ponchon P, Elghozi JL. Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874 [Abstract] [Full Text] [Related]
7. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport. Hatch M, Freel RW, Shahinfar S, Vaziri ND. J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429 [Abstract] [Full Text] [Related]
9. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats. Soltis EE. J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197 [Abstract] [Full Text] [Related]
10. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis]. Gouédard O, Gaudet E, Blanc J, Ponchon P, Elghozi JL. Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370 [Abstract] [Full Text] [Related]
11. Telemetric blood pressure monitoring in benign 2-kidney, 1-clip renovascular hypertension: effect of chronic caffeine ingestion. Kost CK, Li P, Pfeifer CA, Jackson EK. J Pharmacol Exp Ther; 1994 Sep; 270(3):1063-70. PubMed ID: 7932154 [Abstract] [Full Text] [Related]
13. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL. J Clin Invest; 1996 Jul 15; 98(2):418-25. PubMed ID: 8755652 [Abstract] [Full Text] [Related]
14. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Kabour A, Henegar JR, Devineni VR, Janicki JS. Cardiovasc Res; 1995 Apr 15; 29(4):543-8. PubMed ID: 7796449 [Abstract] [Full Text] [Related]
16. Angiotensin II receptors and angiotensin II receptor antagonists. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Pharmacol Rev; 1993 Jun 15; 45(2):205-51. PubMed ID: 8372104 [No Abstract] [Full Text] [Related]
17. Discovery of losartan, the first angiotensin II receptor antagonist. Timmermans PB, Duncia JV, Carini DJ, Chiu AT, Wong PC, Wexler RR, Smith RD. J Hum Hypertens; 1995 Nov 15; 9 Suppl 5():S3-18. PubMed ID: 8583479 [Abstract] [Full Text] [Related]
18. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system. Garcia R, Bonhomme MC, Diebold S. J Hypertens; 1996 Jan 15; 14(1):81-9. PubMed ID: 12013499 [Abstract] [Full Text] [Related]
20. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats. Sacerdote A, Cosenzi A, Bocin E, Molino R, Seculin P, Plazzotta N, Luxich E, Bellini G. J Hypertens; 1995 Dec 15; 13(12 Pt 2):1670-3. PubMed ID: 8903630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]